OPEN ACCESS: All Drugs agency consults on early access to drugs in development: The UK Medicines and Healthcare Products Regulatory Agency has launched a 12 week public consultation on proposals to launch a scheme that gives patients with life threatening, chronic, or debilitating conditions early access to drugs that are still being developed, usually having completed phase III trials but sometimes having just completed phase II. Comments can be emailed to the agency at earlyaccess@mhra.gsi.gov.uk until 5 October.
Doctors need to learn about prescribing exercise: Too few …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking